How PBPK Modeling Will Make Drugs Safer, Cheaper, and More Effective
Historically, drugs have been selected using various methods (eg, biological and chemical screens). Candidate drugs were often pushed into the clinic with only a rudimentary understanding of the link between drug exposure and resultant effect(s). As a consequence, drug development has been inefficient by relying on trial and error at the clinical stage, not to … Continued